
Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study
Keywords: آمپیوئید بتا پپتیدهای; Alzheimer's disease; CAD106; Active immunotherapy; Amyloid-beta peptides; Safety; Biological biomarkers;